A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Condition: Acute Myeloid Leukemia and Myelodysplastic Syndrome Intervention: Drug: QLF32101 Sponsor: Qilu Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Research | Study